Nanomedicine: Nanotechnology, Biology, and Medicine
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 4.3 | Q2 | 67.0% | 0.845 | Q1 | 79.0% |
| 2024 | 4.6 | Q2 | 74.4% | 0.950 | Q1 | 82.8% |
| 2023 | 4.2 | Q2 | 49.4% | 0.863 | Q1 | 81.9% |
| 2022 | 5.4 | Q2 | 58.0% | 0.899 | Q1 | 83.7% |
| 2021 | 6.5 | Q2 | 68.4% | 1.019 | Q1 | 86.9% |
| 2020 | — | — | 1.263 | Q1 | 89.8% | |
| 2019 | — | — | 1.372 | Q1 | 91.4% | |
| 2018 | — | — | 1.508 | Q1 | 91.9% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1549-9642
ISSN
1549-9634
country
UScoverage
2005-2026